Health Plan News logo

Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019

According to the new research report “Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) – Global Forecast to 2019″ published by MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected to reach $1,712.1 Million by 2019 from $1,070.7 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019..

Browse 84 market data tables and 40 figures spread through 185 pages and in-depth TOC on “Oligonucleotide Synthesis Market”

http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

Based on products and services, the market is broadly segmented into equipment, reagents, and synthesized oligonucleotides. Among these segments, the synthesized oligonucleotides market segment is expected to register the highest growth rate during the forecast period, owing to the increasing number of applications of synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos.

The market by applications is classified into diagnostics, research, and therapeutics. Research applications are further segmented into PCR, qPCR, sequencing, gene synthesis, and others. The therapeutics market is further segmented into DNA/antisense oligos, RNAi, aptamers, and others. In terms of applications, the research segment commanded the largest share in 2014, while the diagnostics segment is forecasted to be the fastest-growing segment in the Oligonucleotide Synthesis Market. By end users, the market is segmented into academic research institutes, pharmaceutical and biotech firms, and diagnostic labs. Academic research institutes contributed the major market share in 2014; however, diagnostic laboratories are expected to be the fastest-growing end user segment during the forecast period.

Based on geography, the global Oligonucleotide Synthesis Market is segmented into North America, Latin America, Europe, Middle East and Africa, and Asia-Pacific (APAC). North America is expected to account for the largest share of the market in 2014. However, Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to increase in research and development activities, rising R&D funding and growing availability of synthesized oligos in the region.



  • August 29th 2014
    Tags: Healthcare Plan News

    Comments Off

    Rising Medical Solutions Named to Inc. 500|5000 List

    For the seventh consecutive year, Rising Medical Solutions (Rising) has earned a spot on Inc. magazine's Inc. 500|5000 list, an exclusive ranking of the nation's fastest-growing private companies. The honor roll represents the most comprehensive look at a vital component of the economy—America's independent businesses. Companies such as Microsoft, Zappos, ...
    August 29th 2014
    Tags: Healthcare Plan News

    Comments Off

    New Study: MedStar Washington Hospital Center Demonstrates Home Healthcare Produces Big Savings for the Medicare Program

    A new study published in the Journal of American Geriatrics Society found that house calls to elderly patients with chronic conditions keep healthcare costs down by reducing the need for expensive emergency room visits. The patients who utilize this care are some of Medicare's most costly patients with multiple ...
    August 29th 2014
    Tags: Healthcare Plan News

    Comments Off

    Buckeye Health Plan Has New Name, New Look

    Buckeye Health Plan (Buckeye), formerly known as Buckeye Community Health Plan, today announced a new name and look designed to project the innovative, customer-centered mission and goals of the company. During the past few years, Buckeye has experienced growth in its member base and has expanded across the State of Ohio. ...
    August 29th 2014
    Tags: Healthcare Plan News

    Comments Off

    Capital BlueCross Statement of Support – Healthy Pennsylvania

    Capital BlueCross has long supported programs that increase access to health care and health coverage for our community. This tradition of service continues through our work with the Children's Health Insurance Program and most recently with our involvement in Governor Corbett's proposed Healthy Pennsylvania plan to cover many uninsured ...
    August 29th 2014
    Tags: AARP

    Comments Off

    AARP Pennsylvania Issues Statement in Response to Approval of Waiver Expanding State Medicaid Program

    AARP Pennsylvania released the following statement in response to federal officials today approving a waiver to expand Medicaid for Pennsylvania: "AARP Pennsylvania is pleased that an agreement has been reached to provide health coverage to more than 500,000 hard-working Pennsylvanians – including 90,000 residents age 50-64 – many of whom are ...

    Search

    The archives run deep. Feel free to search older content using topic keywords.